pre-seed
Stage
About
AdipoPharma is a French biotechnology company developing a first-in-class therapeutic peptide, PATAS, which targets adipocyte cells to treat insulin resistance, type 2 diabetes, and related metabolic comorbidities.
Explore AdipoPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.